Shopping Cart
Remove All
Your shopping cart is currently empty
GC-78-HCl is an orally active, non-peptidic SARS-CoV-2 Mpro inhibitor with an enzyme IC50 of 0.19 μM. It exhibits strong anti-coronavirus activity and favorable pharmacokinetic properties.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | GC-78-HCl is an orally active, non-peptidic SARS-CoV-2 Mpro inhibitor with an enzyme IC50 of 0.19 μM. It exhibits strong anti-coronavirus activity and favorable pharmacokinetic properties. |
| In vitro | GC-78-HCl (0.01-10 μM) exhibits low cytotoxicity in Vero E6 cells. It demonstrates effective antiviral activity against SARS-CoV-2 variants and other human coronaviruses in MRC-5 and Vero E6 cells, suggesting potential broad-spectrum anti-coronavirus efficacy. Additionally, GC-78-HCl (50 μM) does not inhibit human cathepsins B, F, K, L, and Caspase 3, indicating high target specificity for coronavirus proteases. |
| In vivo | GC-78-HCl (800 mg/kg, oral administration, single dose) exhibits no acute toxicity in Kunming mice. |
| Molecular Weight | 551.85 |
| Formula | C25H25Cl3N4O4 |
| Cas No. | 3022242-53-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.